Price T Rowe Associates Inc Quest Diagnostics Inc Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 7,194,697 shares of DGX stock, worth $986 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
7,194,697
Previous 5,984,238 20.23%
Holding current value
$986 Million
Previous $1.01 Billion 27.64%
% of portfolio
0.15%
Previous 0.12%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
1,210,459 Added 20.23%
7,194,697 $1.29 Billion
Q1 2025

May 14, 2025
BUY
N/A
493,960 Added 9.0%
5,984,238 $1.01 Billion
Q4 2024

Feb 14, 2025
BUY
N/A
1,637,525 Added 42.5%
5,490,278 $828 Million
Q3 2024

Nov 14, 2024
BUY
$137.09 - $137.09 $507 Million - $507 Million
3,697,500 Added 2381.6%
3,852,753 $598 Million
Q2 2024

Aug 14, 2024
BUY
$125.91 - $144.34 $361,235 - $414,111
2,869 Added 1.88%
155,253 $21.3 Million
Q1 2024

May 15, 2024
SELL
$123.78 - $142.11 $303 Million - $348 Million
-2,451,774 Reduced 94.15%
152,384 $20.3 Million
Q4 2023

Feb 14, 2024
BUY
$120.62 - $141.12 $47.8 Million - $55.9 Million
396,447 Added 17.96%
2,604,158 $359 Million
Q3 2023

Nov 14, 2023
BUY
$121.86 - $144.92 $83 Million - $98.7 Million
680,883 Added 44.59%
2,207,711 $269 Million
Q2 2023

Aug 14, 2023
BUY
$130.56 - $146.84 $180 Million - $202 Million
1,376,308 Added 914.37%
1,526,828 $215 Million
Q1 2023

May 15, 2023
SELL
$131.53 - $155.76 $150 Million - $177 Million
-1,136,976 Reduced 88.31%
150,520 $21.3 Million
Q4 2022

Feb 14, 2023
SELL
$123.31 - $157.26 $50 Million - $63.8 Million
-405,451 Reduced 23.95%
1,287,496 $201 Million
Q3 2022

Nov 14, 2022
BUY
$121.77 - $141.1 $69.1 Million - $80.1 Million
567,417 Added 50.41%
1,692,947 $208 Million
Q2 2022

Aug 15, 2022
BUY
$127.07 - $145.39 $121 Million - $138 Million
952,037 Added 548.75%
1,125,530 $150 Million
Q1 2022

May 16, 2022
SELL
$129.09 - $164.35 $1.46 Million - $1.86 Million
-11,297 Reduced 6.11%
173,493 $23.7 Million
Q4 2021

Feb 14, 2022
SELL
$140.36 - $173.01 $754,575 - $930,101
-5,376 Reduced 2.83%
184,790 $32 Million
Q3 2021

Nov 15, 2021
SELL
$132.95 - $158.0 $2.22 Million - $2.64 Million
-16,731 Reduced 8.09%
190,166 $27.6 Million
Q2 2021

Aug 16, 2021
SELL
$126.66 - $141.48 $1.06 Million - $1.19 Million
-8,378 Reduced 3.89%
206,897 $27.3 Million
Q1 2021

May 17, 2021
SELL
$114.63 - $133.34 $2.07 Million - $2.41 Million
-18,096 Reduced 7.75%
215,275 $27.6 Million
Q4 2020

Feb 16, 2021
BUY
$112.7 - $128.05 $26.3 Million - $29.9 Million
233,371 New
233,371 $27.8 Million

Others Institutions Holding DGX

# of Institutions
1,093
Shares Held
107M
Call Options Held
454K
Put Options Held
615K
View Full List

About QUEST DIAGNOSTICS INC

DGX Quotes by TradingView
  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email